| abstract |
The present invention features compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof, and describes methods of using the same to inhibit the metabolizing activities of CYP enzymes. The present invention also describes methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by CYP enzymes. |